Table 2.
Univariate and Multivariate Analyses for Dissatisfaction. OR > 1 Means a Positive Correlation with Dissatisfaction for the First Indicated Category of the Variables Included
| Variables | Univariate Analysis | Multivariate Analysis | ||
|---|---|---|---|---|
| OR (95% CI) | p | OR (95% CI) | p | |
| Age | ||||
| <65 vs ≥65 ys | 1.38 (1.20–1.59) | < 0.01 | 1.29 (1.12–1.50) | < 0.01 |
| Cancer stage | ||||
| Locoregional vs metastatic | 1.45 (1.19–1.78) | < 0.01 | 1.53 (1.22–1.91) | < 0.01 |
| KPS | ||||
| >40 vs ≤40 | 1.71 (1.42–2.07) | < 0.01 | 1.63 (1.33–1.99) | < 0.01 |
| Anticancer treatment | ||||
| No vs yes | 1.35 (1.14–1.59) | < 0.01 | 1.42 (1.19–1.69) | < 0.01 |
| Type background pain | ||||
| Neuropathic/mixed vs nociceptive | 1.23 (1.05–1.44) | 0.01 | 1.17 (0.81–1.67) | 0.41 |
| Type BTcP | ||||
| Neuropathic/mixed vs nociceptive | 1.21 (1.04–1.41) | 0.02 | 1.03 (0.72–1.48) | 0.86 |
| NSAIDs/paracetamol use | ||||
| Yes vs no | 1.68 (1.44–1.95) | < 0.01 | 1.56 (1.34–1.82) | < 0.01 |
| BTcP interference ADLs | ||||
| High vs low | 2.46 (1.92–3.14) | < 0.01 | 2.34 (1.81–3.01) | < 0.01 |